@PerkinWerbecque @MHRAgovuk The entire industry is built off the back of decades of work by 'illicit' or 'black market' breeders - to try discredit them is morally bankrupt.
Cultivars inform of genetic lineage, and potential medicinal properties - to remove them is like trying to remove medical consent.
@MedBudUK@ScriptAssistUK@CB1Medical@ClinicsIntegro Thanks. I’m with integrity so been eagerly awaiting a system we can easily order medicines on. The current system of inaccessible spreadsheets and constant back and forth emails and phone calls is so inefficient.
Hey @ScriptAssistUK - can you provide an update and ETA on when your app will be available for patients to use and order medicine with?
You previously started it would be rolled out at the end of September and we are quickly approaching December.
What’s the hold up? @MedBudUK
@stevoknevo_@MedBudUK@mamedicauk All these medical cannabis companies need to have a serious word with themselves. The recent trend in pricing of medicinal flower is criminal
@MedBudUK@steve4good Navigating the system is already tough. Cannabis-naive patients feel anxious enough discussing it in their first appointment. I was first prescribed confusing products like EMT-1/2/9000, adding to the confusion. Cultivar names give me more insight into my care than codes ever did
@MedBudUK@IPS_Pharma@ClinicsIntegro Yeah it’s really not, they are usually one of the best and quickest pharmacies. Just glad I’m gonna have the new strains before the weekend and ready in time for my holiday!
Tried @IPS_Pharma again today and I’m still being told that patients cannot place orders for the new GK strains until next week.
I’ve already paid for my repeat prescription fee with @ClinicsIntegro and pharmacies should be able to order this in so why they delay?
@MedBudUK
1/ 🚨 New @UKCanCouncil Report:
Failing to accommodate tenants using prescribed cannabis could breach the Equality Act 2010, leading to serious legal consequences. Here’s what you need to know:👇
https://t.co/LLGOZ5bv62
@MedBudUK@IPS_Pharma@ClinicsIntegro Thanks. I will call IPS in the morning for some explanation and if I don’t have any joy I’ll try calling Integro and ask if they can send my prescription to another pharmacy because this delay seems ridiculous.
@MedBudUK@IPS_Pharma@ClinicsIntegro Latest update from @IPS_Pharma on the new GK. I’m now told the ETA is for payment links to be sent out next Friday 13 September. This delay is really not on.
Any idea which pharmacies have stock available to dispense to patients?
Some thoughts on the current state of the CBPM market in the UK. Legal access to medicinal cannabis in the UK didn’t arise from carefully considered, well designed public policy formulation. Instead it was introduced in exceptional circumstances and rushed through in the summer of 2018. Since then it has been left to regulators, principally the MHRA and CQC, to oversee the process of approving products and prescribing procedures. Alongside this the Home Office have been issuing commercial licences to promote domestic supply of cannabis to support this new market. Throughout this period there has been very little evidence of any coordination of public policy across departments and agencies. Into this arena a suite of new companies emerged backed by investors covering all aspects of the supply chain, cultivation and production, manufacturing and processing, distribution and logistics and prescribing and dispensing. Over the past three years the established model for engaging with patients and administering prescriptions of unlicensed medicines has been via a telemedicine-enabled ‘medical cannabis clinic’ model Competition between these clinics has been intense as they increasingly target a cohort of individuals who have a history of self medicating with cannabis they accessed in the black market or have grown themselves. Social media posts and adoption of product names more commonly associated with the illicit market have been the principal means to reach these patients. Some clinics collect and publish data to aid better clinical understanding but they remain the exception rather than the rule. In recent months tensions long simmering privately have become public with accusations of the market operating in a ‘pseudo-recreational’ fashion coming from senior clinicians within the sector, news articles focusing on product brands and a call for a multi agency review of the sector by the CQC in its annual report on the prescribing of controlled substances. In 2023 a debate took place across the sector regarding the development of an industry wide code of conduct to promote self regulation, professionalism, ethics and transparency but ultimately was eschewed having elicited significant pushback from many clinics. I felt it was a vital opportunity shunned and one that would backfire. In 2024 there is no public clamour to legalise cannabis in the UK, no professional campaigning lobbying for change or any evident mainstream political momentum to as much as consider the issue. Companies operating in the sector should harbour no delusions about the nature of the market they will operate in for the foreseeable future. It will be more medical, more tightly regulated and increasingly subjected to media scrutiny. The inevitable forthcoming government review is necessary and should be welcomed by the sector, investors and patients. It will, in time, remove ambiguity and reduce the precariousness for businesses operating in the marketplace and hopefully produce the first coherent cross government regulatory oversight of the sector.
🧵 Landlords, property managers & housing associations risk breaching the Equality Act over their approach to prescription cannabis usage in properties, according to a new CIC report. 1/5
Nothing to be proud of @Steve4Good, you're celebrating delays to various medications now being restocked, directly affecting patient healthcare.
An attempt to anonymise medication cultivars and brands isn't in either clinicians nor patients best interest.
@MedBudUK@IPS_Pharma Just tried to order the new GK but @IPS_Pharma are saying they can only order it in today so it won’t be available to order for patients until end of the week or start of next. Really not ideal, so now this product is sitting on a shelf for an extra week before we can get it?